Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where S Cayphas is active.

Publication


Featured researches published by S Cayphas.


The EMBO Journal | 1987

B cell growth modulating and differentiating activity of recombinant human 26-kd protein (BSF-2, HuIFN-beta 2, HPGF)

P Poupart; Peter Vandenabeele; S Cayphas; Jacques Van Snick; Guy Haegeman; Véronique Kruys; Walter Fiers

The human ‘26‐kd protein’ is a secreted glycoprotein expressed, for example, in (blood) leukocytes, in epithelial cells treated with various inducers, but most strongly in interleukin‐1 (IL‐1)‐treated fibroblasts. After finding it has antiviral and 2‐5A synthetase‐inducing activity, one group of authors called this protein IFN‐beta 2. However, recently the full‐length 26‐kd cDNA sequence was shown to be identical with that of a B‐cell‐differentiating lymphokine called BSF‐2, and another report suggested that the 26‐kd protein could support the growth of some transformed murine B cell lines. To define its biological activities, we expressed the recombinant 26‐kd protein by translating in Xenopus laevis oocytes a pure, synthetic chimeric mRNA containing the 26‐kd protein coding region surrounded by Xenopus laevis beta‐globin untranslated regions. A similar construction, but containing the HuIFN‐beta cDNA coding region, was used to produce HuIFN‐beta by the same procedure. Both recombinant glycoproteins were secreted, glycosylated, and their amounts were measured by [35S]methionine incorporation by the oocyte. Here we show that the recombinant 26‐kd protein exhibits a high growth factor activity when assayed on an IL‐HP1‐dependent murine B cell hybridoma (sp. act. approximately 2 X 10(8) U/mg) as well as a potent differentiating activity on human CESS cells (sp. act. approximately 5 X 10(7) U/mg). While rHuIFN‐beta was inactive in the latter two assays, it had the expected antiviral activity of 1‐5 X 10(8) U/mg. The parallel recombinant 26‐kd protein preparations had no detectable antiviral activity (i.e. a maximal specific activity of 1‐3 X 10(2) U/mg, if any). The 26‐kd protein is thus clearly an interleukin, and considering the confusing nomenclature now in use, this factor may better be renamed ‘interleukin 6’.


Archive | 1987

The Interrelationship Between Interleukin-1, Interferon-β and Hemopoietic Growth Factors

J. Van Damme; M. De Ley; S Cayphas; Ghislain Opdenakker; J Van Snick; An Billiau

Cytokines are humoral factors which play an important role in immunity. They are produced in extremely small quantities, but can be detected in vitro due to their very high specific activity in various biological tests, such as growth assays, in which they are active at the ng level. By the use of advanced purification methods and recombinant techniques, research on identification and production of a number of cytokines has made a tremendous progress. Thus, it has become clear that several biologically defined factors correspond to the same molecular structure.


Proceedings of the National Academy of Sciences of the United States of America | 1986

Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas

J Van Snick; S Cayphas; Anne Vink; Catherine Uyttenhove; Pierre Coulie; Michael R. Rubira; R J Simpson


Journal of Experimental Medicine | 1987

Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor.

J. Van Damme; Ghislain Opdenakker; R J Simpson; Michael R. Rubira; S Cayphas; Anne Vink; An Billiau; J Van Snick


European Journal of Immunology | 1988

cDNA cloning of murine interleukin-HP1: homology with human interleukin 6

Jacques Van Snick; S Cayphas; Jean-Pierre Szikora; Jean-Christophe Renauld; Emiel Van Roost; Thierry Boon; R J Simpson


Journal of Experimental Medicine | 1987

Interleukin-HP1, a T cell-derived hybridoma growth factor that supports the in vitro growth of murine plasmacytomas.

J Van Snick; Anne Vink; S Cayphas; Catherine Uyttenhove


FEBS Journal | 1987

Purification and characterization of human fibroblast‐derived hybridoma growth factor identical to T‐cell‐derived B‐cell stimulatory factor‐2 (interleukin‐6)

Jo Van Damme; S Cayphas; Jacques Van Snick; René Conings; Willy Put; Jean-Pierre Lenaerts; Richard J. Simpson; Alfons Billiau


European Journal of Immunology | 1987

High-affinity binding sites for human 26-kDa protein (interleukin 6, B cell stimulatory factor-2, human hybridoma plasmacytoma growth factor, interferon-beta 2), different from those of type I interferon (alpha, beta), on lymphoblastoid cells.

Pierre Coulie; A. Vanhecke; Julie Van Damme; S Cayphas; P. Poupart; L. De Wit


Journal of Immunology | 1987

Identification of an interleukin HP1-like plasmacytoma growth factor produced by L cells in response to viral infection.

S Cayphas; J. Van Damme; Anne Vink; R J Simpson; An Billiau; J Van Snick


European Journal of Immunology | 1987

Interleukin-HP1-related hybridoma and plasmacytoma growth factors induced by lipopolysaccharide in vivo.

Pierre Coulie; S Cayphas; Anne Vink; Catherine Uyttenhove; Jacques Van Snick

Collaboration


Dive into the S Cayphas's collaboration.

Top Co-Authors

Avatar

Anne Vink

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

J Van Snick

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Jacques Van Snick

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

R J Simpson

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Catherine Uyttenhove

Ludwig Institute for Cancer Research

View shared research outputs
Top Co-Authors

Avatar

Pierre Coulie

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

An Billiau

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

J. Van Damme

Katholieke Universiteit Leuven

View shared research outputs
Top Co-Authors

Avatar

A. Vanhecke

Université catholique de Louvain

View shared research outputs
Top Co-Authors

Avatar

Alfons Billiau

Katholieke Universiteit Leuven

View shared research outputs
Researchain Logo
Decentralizing Knowledge